
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
San Francisco - Topical preparations remain the first-line therapy for pruritus and often include such old-fashioned therapies as medicated baths, wet dressings, and shake lotions to induce feelings of coolness or heat, Jana Hercogov?, M.D., said at the annual meeting of the American Academy of Dermatology.






